CRIS Current Research Information System

BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.737
EU - Europa 19.107
AS - Asia 7.496
AF - Africa 915
SA - Sud America 66
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 12
Totale 48.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.674
IT - Italia 6.287
GB - Regno Unito 4.289
CN - Cina 2.586
VN - Vietnam 2.217
SE - Svezia 2.149
DE - Germania 1.850
SG - Singapore 1.324
UA - Ucraina 1.088
IN - India 849
FR - Francia 721
IE - Irlanda 670
RU - Federazione Russa 575
CH - Svizzera 403
TG - Togo 374
EE - Estonia 330
ZA - Sudafrica 327
BG - Bulgaria 216
JO - Giordania 216
IR - Iran 98
BE - Belgio 88
FI - Finlandia 84
CI - Costa d'Avorio 80
GR - Grecia 79
SC - Seychelles 79
JP - Giappone 57
NL - Olanda 56
CA - Canada 52
ES - Italia 48
NG - Nigeria 42
AT - Austria 30
PL - Polonia 26
LB - Libano 25
HR - Croazia 23
BR - Brasile 22
TR - Turchia 22
HK - Hong Kong 21
RO - Romania 20
AU - Australia 18
UZ - Uzbekistan 18
CL - Cile 16
CZ - Repubblica Ceca 15
PT - Portogallo 15
MY - Malesia 12
EC - Ecuador 11
IL - Israele 11
KR - Corea 11
AL - Albania 9
EU - Europa 9
PH - Filippine 9
PE - Perù 7
MX - Messico 6
DK - Danimarca 5
SM - San Marino 5
EG - Egitto 4
LT - Lituania 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BO - Bolivia 3
HU - Ungheria 3
LU - Lussemburgo 3
MA - Marocco 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
TW - Taiwan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CU - Cuba 2
KE - Kenya 2
KZ - Kazakistan 2
PK - Pakistan 2
TN - Tunisia 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GL - Groenlandia 1
IM - Isola di Man 1
IQ - Iraq 1
MK - Macedonia 1
MN - Mongolia 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
VA - Santa Sede (Città del Vaticano) 1
Totale 48.354
Salva come PNG Salva come JPEG
Città #
Southend 3.832
Fairfield 2.728
Chandler 2.123
Ashburn 1.654
Dong Ket 1.542
Woodbridge 1.361
Wilmington 1.174
Houston 1.155
Singapore 1.147
Seattle 1.140
Cambridge 984
Princeton 937
Ann Arbor 875
Dublin 661
Jacksonville 655
Padova 409
Rome 409
Nanjing 405
Bologna 399
Westminster 398
Lomé 374
Milan 362
Bern 330
Berlin 270
Santa Clara 240
Amman 216
Sofia 214
Saint Petersburg 198
Jinan 197
Shenyang 191
San Diego 178
Verona 172
Turin 158
Florence 150
Beijing 143
Changsha 138
Medford 132
Boardman 131
Hebei 131
Palermo 131
Mülheim 129
Nanchang 123
New York 105
Dearborn 94
Redmond 88
Brussels 85
Tianjin 83
Abidjan 80
Des Moines 79
Helsinki 79
Redwood City 76
Mahé 74
Naples 74
Bremen 70
Zhengzhou 70
Bari 67
Jiaxing 64
Norwalk 63
Ningbo 61
Guangzhou 59
Shanghai 58
Los Angeles 53
Tokyo 50
Olalla 49
Mountain View 48
Hangzhou 46
Haikou 44
Lanzhou 43
Paris 43
Abeokuta 41
Falls Church 40
Catania 39
Ardabil 37
Kunming 36
Napoli 36
London 34
Taizhou 34
Washington 34
Wuhan 34
Genoa 32
Reggio Emilia 30
Toronto 30
Bühl 29
Taiyuan 28
Cagliari 26
Amsterdam 25
Fuzhou 25
Munich 25
Parma 24
Zanjan 24
Brescia 23
Chicago 23
Frankfurt am Main 23
Hyderabad 23
Messina 22
San Venanzo 22
Hefei 21
Leawood 20
Modena 20
Pisa 20
Totale 30.981
Salva come PNG Salva come JPEG
Nome #
La cardiomiopatia cirrotica. 2.049
L’ipotesi unificante sulla regolazione del volume dei fluidi corporei. Fisiologia e fisiopatologia dell’omeostasi idrosalina, con particolare riguardo allo scompenso cardiaco e alla cirrosi epatica. 1.447
Cirrosi epatica e sue complicanze 592
L’arterializzazione della vena porta per insuffcienza epatica acuta 491
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 320
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 301
Le alterazioni dell’emodinamica sistemica e distrettuale come fattori patogenetici nella cirrosi scompensata. 245
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 224
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 213
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 209
Adaptive response in Hepatitis B virus infection 198
Hyponatremia in patients with cirrhosis of the liver 195
Alcol, sindrome feto-alcolica, apparato ematopoietico, muscolo-scheletrico, respiratorio, cute e reni. 187
A novel model of CCl4-induced cirrosi with ascites in the mouse. 181
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 180
Patologie alcol-relate e trattamento dell’alcolismo. 179
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 179
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 177
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 176
L’albumina nelle malattie del fegato. 176
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 175
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 173
Mutations in the E2-PEPHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma. 172
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. 170
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 170
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection. 168
Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options. 167
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 167
Alcohol and viral hepatitis: a mini-review. 165
null 164
Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. 162
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 160
g-hydroxybutyrate as a treatment for alcoholism. 158
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. 158
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation. 158
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned. 157
Acute alcohol intoxication. 156
Art in hospital: its impact on the feelings and emotional state of patients admitted to an Internal Medicine Unit. 156
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 156
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 152
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 151
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. 148
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 147
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 147
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 147
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 145
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 145
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 145
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 145
Dossier Epatologia: Sindrome epatopolmonare e ipertensione portopolmonare. 144
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 144
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 144
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 143
null 142
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 141
AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions. 141
Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute dcompensation of cirrhosis. 140
First report of fulminant hepatic failure treated with portal v ein arterialization avoiding liver transplantation 139
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. 138
null 138
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 138
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 137
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 137
Duodenal histology in patients with celiac disease after a gluten-free diet 137
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 137
Clinical indications for the albumin use: Still a controversial issue. 137
Cardiac electrophysiological abnormalities in patients with cirrhosis. 136
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 136
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 135
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 135
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 135
Linee-guida per l’uso clinico dell’albumina: l’esperienza del Policlinico S. Orsola-Mallpighi di Bologna. 135
Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. 134
Insufficienza epatica acuta ed epatite subacuta. 134
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 134
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 134
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 134
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 133
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 133
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 131
Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference. 131
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 131
Alcoholic liver disease: pathophisiological aspects and risk factors. A review. 130
Chronic hepatitis B: Are we close to a cure? 130
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 129
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 129
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 129
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 129
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 129
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 128
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 128
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 128
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 127
Assorbimento e metabolismo dell’etanolo. 126
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 126
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 126
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 125
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 125
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 124
Telangiectasia as a presenting sign of Graves’ disease. 123
Totale 19.312
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.279 0 0 0 654 1.097 1.182 1.428 1.464 1.566 777 436 675
2020/20217.244 1.301 496 285 318 182 326 167 397 576 379 406 2.411
2021/20229.160 881 414 551 780 764 492 306 572 351 549 2.106 1.394
2022/20239.778 968 1.374 494 1.169 571 766 362 545 1.609 347 835 738
2023/20243.737 257 502 241 336 306 560 245 328 168 285 239 270
2024/20253.445 444 1.696 885 420 0 0 0 0 0 0 0 0
Totale 49.249